Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Audrik Perez-rodriguez (NPI 1831573294)

Field	Value
Entity Type	Individual
Organization	Audrik Perez-rodriguez
Address	410 E Spruce St
City	Garden City
State	KS
ZIP	67846
Taxonomy	Medical Oncology Physician
NPI Enumerated	July 16, 2015

Payer Source	Total Paid
Medicare	$1.1M
Medicaid	$0

Key Findings

This provider reports $1.1M in total Medicare revenue and has no Medicaid billing on file, making their Medicare activity effectively single-payer in the available data. The top 3 Medicare codes account for 75.1% of Medicare revenue, indicating a concentrated revenue base tied to a small set of services.

The code mix (large volumes of J9271, J0897 and multiple chemotherapy administration codes such as 96413, 96367 and 96417) is consistent with an outpatient oncology infusion practice that delivers both high-cost biologic injections and routine chemotherapy administration. High-revenue drug administration (J9271, J0897) alongside antiemetic/supportive agents (J1454, J1437) suggests integrated oncology treatment with on-site medication delivery and supportive care.

Revenue is highly concentrated in a few drug/injection codes: J9271 generates $490.2K (44.8% of Medicare revenue), J0897 generates $278.6K (25.5%), and 96413 generates $53K (4.8%). These three codes together make up the precomputed 75.1% concentration, signaling that a small set of drugs and infusion services drive the majority of billings.

Competitive standing varies by code: for J0897 the provider ranks #497 of 10057 (95th percentile; notably above typical national volume) and for 96413 the provider ranks #446 of 7514 (94th percentile; notably above typical national volume), indicating above-typical throughput for these chemotherapy/related-product services. By contrast, J9271 ranks #1008 of 1841 (44th percentile; typical, unremarkable volume), so the provider is not a dominant national supplier of pembrolizumab relative to peers despite that code being the single largest revenue line locally.

Several ancillary and infusion-related codes show clear high-volume signals: J1454 ranks #22 of 422 (95th percentile; notably above typical national volume), 96367 ranks #104 of 4032 (97th percentile; notably above typical national volume), 96523 ranks #37 of 1643 (98th percentile; notably above typical national volume), and 96372 ranks #1672 of 58224 (97th percentile; notably above typical national volume). These percentile placements point to operational scale around infusion sessions, device maintenance, and accessory procedures that support a busy infusion clinic.

Evaluation-and-management activity appears to support the infusion service but is not the primary revenue driver: 99214 generated $43.7K (4.0% of Medicare revenue) and 99213 generated $25K (2.3% of Medicare revenue), with both codes described as typical, unremarkable volume despite high national percentile placement. This pattern is consistent with frequent return visits for oncology patients where drug administration, not E/M billing, dominates revenue.

The absence of any Medicaid claims (none below) means there is no observable Medicaid footprint to analyze for payer diversification or state-level market positioning. For payers and network managers, this profile implies contracting and utilization risk is concentrated in Medicare exposure and in a few high-cost drug lines rather than spread across dual-payer mixes.

The provider’s NPI was enumerated on 2015-07-16 (~11 years ago), indicating an established presence in the market long enough to have built a consistent infusion-focused caseload. Combined with the code mix and percentile signals, the data are consistent with a mature, outpatient oncology practice centered on biologic and chemotherapy administration rather than general primary or inpatient care.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

40 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	11,400	$40	$490.2K
J0897	Injection, denosumab, 1 mg	15,480	$20	$278.6K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	580	$90	$53K
J1454	Injection, fosnetupitant 235 mg and palonosetron 0.25 mg	150	$350	$51.1K
J1437	Injection, ferric derisomaltose, 10 mg	2,700	$20	$45.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	510	$90	$43.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	420	$60	$25K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	180	$130	$22.9K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	850	$20	$17.9K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	240	$50	$12.2K

Showing 1–10 of 40

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 40 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Audrik Perez-rodriguez — 1 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

40 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	17	20	28,900	$40	$1.1M
J0897	10	180	2,160	$20	$81.5K
J1437	2	10	2,050	$20	$48.2K
J1454	3	10	90	$350	$31.7K
J9217	15	50	120	$130	$27.4K
96413	16	80	80	$90	$26.3K
99214	497	4,310	120	$70	$16.4K
99233	942	1,110	100	$90	$16.2K
G0498	15	20	90	$110	$10.9K
96401	7	30	180	$50	$9K

Showing 1–10 of 40

Related Providers

Other providers that share a Tax Identification Number (TIN) with Audrik Perez-rodriguez, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Leonid Shunyakov	MO	Medical Oncology Physician	$3.3M	$0
Mark Fesen	KS	Medical Oncology Physician	$1.5M	$0
Claudia Perez-tamayo	KS	Therapeutic Radiology Physician	$1.2M	$0
Central Care, PA	KS	Specialist	$0	$1.2M
Elshami Elamin	KS	Medical Oncology Physician	$459.4K	$0
Ali Wazir	KS	Hematology & Oncology Physician	$343K	$0
Penelope Harris	MO	Hematology & Oncology Physician	$247.5K	$0

Nearby Providers

Other providers in the same ZIP code as Audrik Perez-rodriguez, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Compass Behavioral Health	KS	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$34.4M
Rescare Kansas, Inc.	KS	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$31.6M
Mosaic	KS	Personal Care Attendant	$0	$31.3M
Compass Behavioral Health	KS	Community/Behavioral Health Agency	$0	$17.5M
Destiny Supports, Inc.	KS	Home Health Agency	$0	$14M
Karis, Inc.	KS	Developmentally Disabled Services Day Training Agency	$0	$9.4M
Michael P.harris, D.d.s.,p.a.	KS	Dentist	$0	$5.7M
Commonspirit Kansas, Inc.	KS	Pediatrics Physician	$0	$4.2M
United Methodist Western Kansas Mexican American Ministries, Inc.	KS	Federally Qualified Health Center (FQHC)	$0	$2.9M
United Methodist Western Kansas Mexican-american Ministries, Inc.	KS	Federally Qualified Health Center (FQHC)	$0	$2.5M

Audrik Perez-rodriguez — Billing Profile & Reimbursement Data

Sign up for Audrik Perez-rodriguez — Billing Profile & Reimbursement Data policy alerts

Audrik Perez-rodriguez — Billing Profile & Reimbursement Data

Sign up for Audrik Perez-rodriguez — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References